DOCUMENT AND ENTITY INFORMATION
DOCUMENT AND ENTITY INFORMATION - shares | 9 Months Ended | |
Sep. 30, 2023 | Oct. 27, 2023 | |
Document and Entity Information [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2023 | |
Entity Registrant Name | DHI Group, Inc. | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Small Business | true | |
Entity Common Stock, Shares Outstanding | 46,817,871 | |
Entity File Number | 001-33584 | |
Entity Tax Identification Number | 20-3179218 | |
Entity Address, Address Line One | 6465 South Greenwood Plaza | |
Entity Address, City or Town | Centennial | |
Entity Address, State or Province | CO | |
Entity Address, Postal Zip Code | 80111 | |
Local Phone Number | 448-6605 | |
Trading Symbol | DHX | |
Entity Interactive Data Current | Yes | |
Security Exchange Name | NYSE | |
City Area Code | 212 | |
Entity Central Index Key | 0001393883 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false | |
Entity Address, Address Line Two | Suite 400 | |
Entity Incorporation, State or Country Code | DE | |
Title of 12(b) Security | Common Stock, par value $0.01 per share |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash | $ 3,724 | $ 3,006 |
Accounts receivable, net of allowance for doubtful accounts of $1,272 and $1,374 | 18,591 | 20,494 |
Prepaid and other current assets | 4,791 | 4,294 |
Total current assets | 27,106 | 27,794 |
Fixed assets, net | 23,376 | 21,252 |
Acquired intangible assets, net | 23,800 | 23,800 |
Capitalized contract costs | 6,404 | 9,677 |
Goodwill | 128,100 | 128,100 |
Operating lease right-of-use-assets | 5,096 | 6,581 |
Other assets | 3,998 | 3,854 |
Equity Method Investments | 1,857 | 5,646 |
Total assets | 219,737 | 226,704 |
Current liabilities | ||
Accounts payable and accrued expenses | 15,731 | 23,818 |
Operating lease liabilities - current | 969 | 105 |
Deferred revenue | 48,331 | 50,121 |
Income taxes payable | 107 | 34 |
Total current liabilities | 65,138 | 74,078 |
Long-term debt, net | 40,000 | 30,000 |
Deferred Revenue, Noncurrent | 513 | 743 |
Accrual for unrecognized tax benefits | 1,157 | 769 |
Deferred Tax Liabilities, Tax Deferred Income | 2,336 | 5,515 |
Operating lease liabilities - non-current (as reported) | 6,997 | 8,428 |
Other long-term liabilities | 508 | 932 |
Total liabilities | $ 116,649 | $ 120,465 |
Preferred Stock, Shares Issued | 0 | 0 |
Stockholders equity | ||
Convertible preferred stock, $.01 par value, authorized 20,000 shares; no shares issued and outstanding | $ 0 | $ 0 |
Common stock, $.01 par value, authorized 240,000; issued: 78,569 and 76,442 shares, respectively; outstanding: 46,689 and 47,367 shares, respectively | 787 | 766 |
Additional paid-in capital | 259,481 | 251,632 |
Accumulated other comprehensive loss | (70) | (481) |
Accumulated earnings | 30,080 | 28,405 |
Treasury stock, 31,880 and 29,075 shares, respectively | (187,190) | (174,083) |
Total stockholders' equity | 103,088 | 106,239 |
Total liabilities and stockholders’ equity | $ 219,737 | $ 226,704 |
CONSOLIDATED BALANCE SHEETS (PA
CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.01 | $ 0.01 |
Preferred Stock, Shares Authorized | 20,000,000 | 20,000,000 |
Preferred Stock, Shares Issued | 0 | 0 |
Preferred Stock, Shares Outstanding | 0 | 0 |
Current assets | ||
Allowance for doubtful accounts | $ 1,272 | $ 1,374 |
Stockholders equity | ||
Common stock, par value | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 240,000,000 | 240,000,000 |
Common stock, shares issued | 78,569,000 | 76,442,000 |
Common stock, shares outstanding | 46,689,000 | 47,367,000 |
Statement of Income (Statement)
Statement of Income (Statement) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenue | $ 37,433 | $ 38,527 | $ 114,591 | $ 109,918 |
Operating expenses: | ||||
Cost of revenue | 4,971 | 4,561 | 14,839 | 12,841 |
Product development | 4,432 | 4,680 | 13,284 | 12,982 |
Sales and marketing | 14,036 | 14,992 | 44,819 | 43,207 |
General and administrative | 7,210 | 8,668 | 23,871 | 25,543 |
Depreciation on continuing operations | 4,241 | 4,408 | 12,576 | 12,594 |
Restructuring Costs | 302 | 0 | 2,417 | 0 |
Total operating expenses | 35,192 | 37,309 | 111,806 | 107,167 |
Operating income | 2,241 | 1,218 | 2,785 | 2,751 |
Interest expense and other | 939 | 447 | 2,616 | 990 |
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | 153 | 591 | 428 | 1,107 |
Debt and Equity Securities, Unrealized Gain (Loss) | 614 | 0 | 614 | 320 |
Gain (Loss) on Investments | (300) | (2,300) | (300) | (2,300) |
Income (loss) before income taxes | 1,769 | (938) | 911 | 888 |
Income tax expense (benefit) | 759 | (12) | (432) | (937) |
Net income (loss) | $ 1,010 | $ (926) | $ 1,343 | $ 1,825 |
Basic earnings (loss) per share (in dollars per share) | $ 0.02 | $ (0.02) | $ 0.03 | $ 0.04 |
Diluted earnings (loss) per share (in dollars per share) | $ 0.02 | $ (0.02) | $ 0.03 | $ 0.04 |
Weighted average basic shares outstanding | 43,405 | 44,190 | 43,582 | 44,503 |
Weighted average diluted shares outstanding | 44,324 | 44,190 | 44,579 | 46,711 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) Statement - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income (loss) | $ 1,010 | $ (926) | $ 1,343 | $ 1,825 |
Foreign currency translation adjustment | 55 | (200) | 211 | (250) |
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax | 200 | 0 | 200 | 0 |
Total other comprehensive income (loss) | 255 | (200) | 411 | (250) |
Comprehensive income (loss) | $ 1,265 | $ (1,126) | $ 1,754 | $ 1,575 |
CONSOLIDATED STATEMENT OF STOCK
CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY Statement - USD ($) $ in Thousands | Total | Restricted Stock | Performance Stock Units | Common Stock [Member] | Common Stock [Member] Restricted Stock | Common Stock [Member] Performance Stock Units | Additional Paid-in Capital [Member] | Additional Paid-in Capital [Member] Restricted Stock | Additional Paid-in Capital [Member] Performance Stock Units | Accumulated Earnings (Loss) [Member] | Accumulated Other Comprehensive Loss [Member] | Treasury Stock, Common | Treasury Stock, Common Restricted Stock | Treasury Stock, Common Performance Stock Units |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Treasury Stock, Common, Shares | 24,828,000 | |||||||||||||
Beginning balance (in shares) at Dec. 31, 2021 | 73,584,000 | |||||||||||||
Beginning balance at Dec. 31, 2021 | $ 116,362 | $ 738 | $ 241,854 | $ 24,229 | $ (61) | $ (150,398) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Net income | 1,301 | 1,301 | ||||||||||||
Other comprehensive income (loss) | 8 | 8 | ||||||||||||
Stock based compensation | 2,235 | 2,235 | ||||||||||||
Restricted stock issued (in shares) | (932,000) | |||||||||||||
Restricted stock issued | 0 | $ (9) | (9) | |||||||||||
Forfeited (in shares) | (1,773,000) | |||||||||||||
Shares Granted, Value, Share-based Payment Arrangement, Forfeited | 0 | $ (17) | 17 | |||||||||||
Shares forfeited or withheld to satisfy tax obligations (in shares) | (82,000) | (93,000) | (417,000) | (356,000) | ||||||||||
Share-based payment arrangement, decrease for tax withholding obligation | $ (2,309) | $ (1,893) | $ (1) | $ (1) | $ 1 | $ 1 | $ (2,309) | $ (1,893) | ||||||
Purchase of treasury stock under stock repurchase plan (in shares) | 1,302,000 | |||||||||||||
Purchase of treasury stock under stock repurchase plan | (7,499) | $ (7,499) | ||||||||||||
Ending balance (in shares) at Mar. 31, 2022 | 76,114,000 | |||||||||||||
Ending balance at Mar. 31, 2022 | 108,205 | $ 762 | 244,065 | 25,530 | (53) | (162,099) | ||||||||
Beginning balance (in shares) at Dec. 31, 2021 | 73,584,000 | |||||||||||||
Beginning balance at Dec. 31, 2021 | 116,362 | $ 738 | 241,854 | 24,229 | (61) | (150,398) | ||||||||
Ending balance (in shares) at Sep. 30, 2022 | 76,403,000 | |||||||||||||
Ending balance at Sep. 30, 2022 | 105,334 | $ 764 | 249,139 | 26,054 | (311) | $ (170,312) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Treasury Stock, Common, Shares | 26,903,000 | |||||||||||||
Beginning balance (in shares) at Mar. 31, 2022 | 76,114,000 | |||||||||||||
Beginning balance at Mar. 31, 2022 | 108,205 | $ 762 | 244,065 | 25,530 | (53) | $ (162,099) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Net income | 1,450 | 1,450 | ||||||||||||
Other comprehensive income (loss) | (58) | (58) | ||||||||||||
Stock based compensation | 2,456 | 2,456 | ||||||||||||
Shares forfeited or withheld to satisfy tax obligations (in shares) | (26,000) | 0 | (59,000) | (5,000) | ||||||||||
Share-based payment arrangement, decrease for tax withholding obligation | (349) | (22) | $ (1) | $ 0 | 0 | 0 | $ (348) | $ (22) | ||||||
Purchase of treasury stock under stock repurchase plan (in shares) | 625,000 | |||||||||||||
Purchase of treasury stock under stock repurchase plan | (3,701) | $ (3,701) | ||||||||||||
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition | $ 124 | |||||||||||||
Stock Issued During Period, Shares, Employee Stock Purchase Plans | 29,000 | |||||||||||||
Stock Issued During Period, Value, Employee Stock Purchase Plan | $ 0 | |||||||||||||
Ending balance (in shares) at Jun. 30, 2022 | 76,117,000 | |||||||||||||
Ending balance at Jun. 30, 2022 | 108,105 | $ 761 | 246,645 | 26,980 | (111) | $ (166,170) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Treasury Stock, Common, Shares | 27,592,000 | |||||||||||||
Net income | (926) | (926) | ||||||||||||
Other comprehensive income (loss) | (200) | (200) | ||||||||||||
Stock based compensation | 2,497 | 2,497 | ||||||||||||
Restricted stock issued | 0 | |||||||||||||
Shares forfeited or withheld to satisfy tax obligations (in shares) | 294,000 | (8,000) | (88,000) | |||||||||||
Share-based payment arrangement, decrease for tax withholding obligation | (379) | $ 3 | $ 0 | (3) | 0 | $ (379) | ||||||||
Purchase of treasury stock under stock repurchase plan (in shares) | 720,000 | |||||||||||||
Purchase of treasury stock under stock repurchase plan | (3,763) | $ (3,763) | ||||||||||||
Ending balance (in shares) at Sep. 30, 2022 | 76,403,000 | |||||||||||||
Ending balance at Sep. 30, 2022 | $ 105,334 | $ 764 | 249,139 | 26,054 | (311) | $ (170,312) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Treasury Stock, Common, Shares | 28,400,000 | |||||||||||||
Treasury Stock, Common, Shares | 29,075,000 | 29,075,000 | ||||||||||||
Beginning balance (in shares) at Dec. 31, 2022 | 47,367,000 | 76,442,000 | ||||||||||||
Beginning balance at Dec. 31, 2022 | $ 106,239 | $ 766 | 251,632 | 28,405 | (481) | $ (174,083) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Net income | 460 | 460 | ||||||||||||
Other comprehensive income (loss) | 150 | 150 | ||||||||||||
Stock based compensation | 2,887 | 2,887 | ||||||||||||
Restricted stock issued (in shares) | (1,107,000) | |||||||||||||
Restricted stock issued | 0 | $ (11) | (11) | |||||||||||
Forfeited (in shares) | (1,288,000) | |||||||||||||
Shares Granted, Value, Share-based Payment Arrangement, Forfeited | 0 | $ (13) | 13 | |||||||||||
Shares forfeited or withheld to satisfy tax obligations (in shares) | (4,000) | 0 | (386,000) | (512,000) | ||||||||||
Share-based payment arrangement, decrease for tax withholding obligation | (2,278) | (3,017) | $ 0 | $ 0 | 0 | 0 | $ (2,278) | $ (3,017) | ||||||
Purchase of treasury stock under stock repurchase plan (in shares) | 743,000 | |||||||||||||
Purchase of treasury stock under stock repurchase plan | (3,521) | $ (3,521) | ||||||||||||
Ending balance (in shares) at Mar. 31, 2023 | 78,833,000 | |||||||||||||
Ending balance at Mar. 31, 2023 | $ 101,252 | $ 790 | 254,495 | 29,197 | (331) | (182,899) | ||||||||
Beginning balance (in shares) at Dec. 31, 2022 | 47,367,000 | 76,442,000 | ||||||||||||
Beginning balance at Dec. 31, 2022 | $ 106,239 | $ 766 | 251,632 | 28,405 | (481) | (174,083) | ||||||||
Ending balance (in shares) at Sep. 30, 2023 | 46,689,000 | 78,569,000 | ||||||||||||
Ending balance at Sep. 30, 2023 | $ 103,088 | $ 787 | 259,481 | 30,080 | (70) | $ (187,190) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Cumulative-effect of new accounting principle | 332 | 332 | ||||||||||||
Treasury Stock, Common, Shares | 30,716,000 | |||||||||||||
Beginning balance (in shares) at Mar. 31, 2023 | 78,833,000 | |||||||||||||
Beginning balance at Mar. 31, 2023 | 101,252 | $ 790 | 254,495 | 29,197 | (331) | $ (182,899) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Net income | (127) | (127) | ||||||||||||
Other comprehensive income (loss) | 6 | 6 | ||||||||||||
Stock based compensation | 2,667 | 2,667 | ||||||||||||
Restricted stock issued (in shares) | (176,000) | |||||||||||||
Restricted stock issued | 0 | $ (2) | (2) | |||||||||||
Shares forfeited or withheld to satisfy tax obligations (in shares) | (183,000) | (110,000) | (26,000) | 0 | ||||||||||
Share-based payment arrangement, decrease for tax withholding obligation | (95) | 0 | $ (2) | $ (1) | 2 | 1 | $ (95) | $ 0 | ||||||
Purchase of treasury stock under stock repurchase plan (in shares) | 919,000 | |||||||||||||
Purchase of treasury stock under stock repurchase plan | (3,375) | $ (3,375) | ||||||||||||
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition | $ 148 | |||||||||||||
Stock Issued During Period, Shares, Employee Stock Purchase Plans | 45,000 | |||||||||||||
Stock Issued During Period, Value, Employee Stock Purchase Plan | $ 0 | |||||||||||||
Ending balance (in shares) at Jun. 30, 2023 | 78,761,000 | |||||||||||||
Ending balance at Jun. 30, 2023 | 100,476 | $ 789 | 257,311 | 29,070 | (325) | $ (186,369) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Treasury Stock, Common, Shares | 31,661,000 | |||||||||||||
Net income | 1,010 | 1,010 | ||||||||||||
Other comprehensive income (loss) | 55 | 55 | ||||||||||||
Stock based compensation | 2,168 | 2,168 | ||||||||||||
Restricted stock issued (in shares) | (307,000) | |||||||||||||
Restricted stock issued | 0 | $ (3) | (3) | |||||||||||
Shares forfeited or withheld to satisfy tax obligations (in shares) | (289,000) | (210,000) | (135,000) | (84,000) | ||||||||||
Share-based payment arrangement, decrease for tax withholding obligation | $ (501) | $ (320) | $ (3) | $ (2) | $ 3 | $ 2 | $ (501) | $ (320) | ||||||
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax | $ 200 | 200 | ||||||||||||
Ending balance (in shares) at Sep. 30, 2023 | 46,689,000 | 78,569,000 | ||||||||||||
Ending balance at Sep. 30, 2023 | $ 103,088 | $ 787 | $ 259,481 | $ 30,080 | $ (70) | $ (187,190) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Treasury Stock, Common, Shares | 31,880,000 | 31,880,000 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash flows from operating activities: | ||
Net income (loss) | $ 1,343 | $ 1,825 |
Adjustments to reconcile net income to net cash flows from operating activities: | ||
Depreciation | 12,576 | 12,594 |
Deferred income taxes | (3,179) | (3,682) |
Amortization of deferred financing costs | 109 | 110 |
Stock-based compensation | 7,722 | 7,188 |
Income (Loss) from Equity Method Investments | (428) | (1,107) |
Equity Securities, FV-NI, Gain (Loss) | (614) | (320) |
Change in accrual for unrecognized tax benefits | 388 | 208 |
Impairment on investment | 300 | 2,300 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 2,236 | (476) |
Prepaid expenses and other assets | (750) | (547) |
Capitalized contract costs | 3,273 | 410 |
Accounts payable and accrued expenses | (7,799) | 3,807 |
Income taxes receivable/payable | 73 | 735 |
Deferred revenue | (2,020) | 6,106 |
Other, net | 494 | (465) |
Net cash flows from operating activities | 13,724 | 28,686 |
Proceeds from Sale of Equity Method Investments | 4,941 | 320 |
Cash flows from (used in) investing activities: | ||
Purchases of fixed assets | (14,988) | (13,393) |
Net cash flows used in investing activities | (10,047) | (13,073) |
Cash flows from (used in) financing activities: | ||
Payments on long-term debt | (23,000) | (8,000) |
Proceeds from long-term debt | 33,000 | 15,000 |
Payments of Financing Costs | 0 | (515) |
Payments under stock repurchase plan | (6,896) | (14,963) |
Purchase of treasury stock related to vested restricted and performance stock units | (6,211) | (4,951) |
Proceeds from Issuance of Common Stock | 148 | 124 |
Net cash flows used in financing activities | (2,959) | (13,305) |
Net change in cash for the period | 718 | 2,308 |
Cash, beginning of period | 3,006 | 1,540 |
Cash, end of period | $ 3,724 | $ 3,848 |
ORGANIZATION AND PRINCIPAL ACTI
ORGANIZATION AND PRINCIPAL ACTIVITIES (Notes) | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of DHI Group, Inc. (“DHI” or the “Company” or "we," "our" or "us") have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in annual audited consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been omitted and condensed pursuant to such rules and regulations. In the opinion of the Company’s management, all adjustments (consisting of only normal and recurring accruals) have been made to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. Although the Company believes that the disclosures are adequate to make the information presented not misleading, these financial statements should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report on Form 10-K”). Operating results for the three and nine-month periods ended September 30, 2023 are not necessarily indicative of the results to be achieved for the full year. Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Management believes the most complex and sensitive judgments, because of their significance to the condensed consolidated financial statements, result primarily from the need to make estimates about the effects of matters that are inherently uncertain. Actual results could differ materially from management’s estimates reported in the condensed consolidated financial statements and footnotes thereto. There have been no significant changes in the Company’s assumptions regarding critical accounting estimates during the nine-month period ended September 30, 2023. The Company allocates resources and assesses financial performance on a consolidated basis, as all services pertain to the Company's Tech-focused strategy. As a result, t he Company has a single reportable segment, Tech-focused, which includes the Dice and ClearanceJobs brands, as well as corporate related costs. All operations are in the United States. |
SIGNIFCANT ACCOUNTING POLICIES
SIGNIFCANT ACCOUNTING POLICIES (Notes) | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | 2. NEW ACCOUNTING STANDARDS In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | FAIR VALUE MEASUREMENTS The FASB ASC topic on Fair Value Measurements and Disclosures defines fair value, establishes a framework for measuring fair value and requires certain disclosures for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. As a basis for considering assumptions, a three-tier fair value hierarchy is used, which prioritizes the inputs used in measuring fair value as follows: • Level 1 – Quoted prices for identical instruments in active markets. • Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations, in which all significant inputs are observable in active markets. • Level 3 – Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts receivable, other assets, accounts payable and accrued expenses and long-term debt approximate their fair values. Investments, non-current that were carried at fair value, prior to the conversion to preferred shares as described in Note 7, used a discounted cash flow technique based on the probability of one or more possible outcomes, based on Level 3 inputs, which inputs and fair value did not change during the 2022 period prior to the conversion. The estimated fair value of long-term debt is based on Level 2 inputs. Certain assets and liabilities are measured at fair value on a non-recurring basis as they are subject to fair value adjustments in certain circumstances, for example, when there is evidence of impairment. Such instruments are not measured at fair value on an ongoing basis. These assets include equity investments, operating lease right-of-use assets, and goodwill and intangible assets which resulted from prior acquisitions. Items valued using such internally generated valuation techniques are classified according to the lowest level input or value driver that is significant to the valuation. Thus, an item may be classified in Level 3 even though there may be some significant inputs that are readily observable. |
Revenue Recognition (Notes)
Revenue Recognition (Notes) | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | REVENUE RECOGNITION The Company recognizes revenue when control of the promised goods or services is transferred to our customers at an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized net of customer discounts ratably over the service period. Customer billings delivered in advance of services being rendered are recorded as deferred revenue and recognized over the service period. The Company generates revenue from recruitment packages, advertising, classifieds, and virtual and live career fair and recruitment event booth rentals. Disaggregation of Revenue Our brands primarily serve the technology and security cleared professions. The following table provides information about disaggregated revenue by brand and includes a reconciliation of the disaggregated revenue (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Dice (1) $ 24,770 $ 27,342 $ 77,952 $ 78,799 ClearanceJobs 12,663 11,185 36,639 31,119 Total $ 37,433 $ 38,527 $ 114,591 $ 109,918 (1) Includes Dice and Career Events Contract Balances The following table provides information about opening and closing balances of receivables and contract liabilities from contracts with customers as required under Topic 606 (in thousands): As of September 30, 2023 As of December 31, 2022 Receivables $ 18,591 $ 20,494 Short-term contract liabilities (deferred revenue) 48,331 50,121 Long-term contract liabilities (deferred revenue) 513 743 We receive payments from customers based upon contractual billing schedules; accounts receivable are recorded when customers are invoiced per the contractual billings schedules. As the Company's standard payment terms are less than one year, the Company elected the practical expedient, where applicable. As a result, the Company does not consider the effects of a significant financing component. Contract liabilities include customer billings delivered in advance of performance under the contract, and associated revenue is realized when services are rendered under the contract. Receivables increase due to customer billings and decrease by cash collected from customers. Contract liabilities increase due to customer billings and are decreased as performance obligations are satisfied under the contracts. The Company recognized the following revenue as a result of changes in the contract liability balances in the respective periods (in thousands): Three Months Ended Nine Months Ended September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Revenue recognized in the period from: Amounts included in the contract liability at the beginning of the period $ 26,958 $ 26,783 $ 44,660 $ 41,387 The following table includes estimated deferred revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period (in thousands): Remainder of 2023 2024 2025 2026 Total Tech-focused $ 26,438 $ 22,136 $ 249 $ 21 $ 48,844 Credit Losses The Company is exposed to credit losses through the inability of its customers to make required payments on accounts receivable. The Company segments accounts receivable based on credit risk characteristics and estimates future losses for each segment based on historical trends and current market conditions, as applicable. Expected losses on accounts receivable are recorded as allowance for doubtful accounts in the condensed consolidated balance sheets and as an expense in the condensed consolidated statement of operations. The portion of accounts receivable that is reflected as deferred revenue in the condensed consolidated balance sheets is not considered at risk for credit losses. If the financial condition of DHI’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. |
RESTRUCTURE COSTS
RESTRUCTURE COSTS | 9 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
RESTRUCTURE COSTS | RESTRUCTURING In May 2023, the Company announced an organizational restructuring intended to streamline its operations, drive business objectives, reduce operating expenses and improve operating margins. The restructuring included a reduction of the Company’s then-current workforce by approximately 10%. As a result of the restructuring, the Company recognized a charge of $0.3 million and $2.4 million, respectively, for the three and nine-month periods ended September 30, 2023 consisting of $0.1 million and $1.9 million, respectively, of employee severance costs, of which $0.9 million and $1.4 million, respectively, was paid during the periods, and $0.2 million and $0.5 million, respectively, of stock-based compensation related to the acceleration of restricted stock and performance-based restricted stock units. There was no restructuring in 2022. |
LEASES
LEASES | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
LEASES | LEASES The Company has operating leases for corporate office space and certain equipment. The leases have original terms from one year to eleven years, some of which include options to renew the lease, and are included in the lease term when it is reasonably certain that the Company will exercise the option. No leases include options to purchase the leased property. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. We do not have any lease agreements with related parties. The components of lease cost were as follows (in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease cost (1) $ 352 $ 592 $ 1,530 $ 1,636 Sublease income (25) (190) (324) (440) Total lease cost $ 327 $ 402 $ 1,206 $ 1,196 (1) Includes short-term lease costs and variable lease costs, which are immaterial. Supplemental cash flow information related to leases was as follows (in thousands): For the Nine Months Ended September 30, 2023 2022 Cash paid for amounts included in measurement of lease liabilities: Operating cash flows from operating leases $ 1,832 $ 675 Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount): September 30, 2023 December 31, 2022 Operating lease right-of-use-assets $ 5,096 $ 6,581 Operating lease liabilities - current 1,984 2,231 Less: tenant improvement allowance (1,015) (2,126) Operating lease liabilities - current (as reported) 969 105 Operating lease liabilities - non-current (as reported) 6,997 8,428 Total operating lease liabilities $ 7,966 $ 8,533 Weighted Average Remaining Lease Term (in years) Operating leases 6.1 5.8 Weighted Average Discount Rate Operating leases 4.5 % 4.4 % The Company reviews its right-of-use ("ROU") assets for impairment if indicators of impairment exist. The impairment review process compares the fair value of the ROU asset to its carrying value. If the carrying value exceeds the fair value, an impairment loss is recorded. No impairment was recorded during the three and nine month periods ended September 30, 2023 and 2022. As of September 30, 2023, future operating lease payments were as follows (in thousands): Operating Leases October 1, 2023 through December 31, 2023 $ 478 2024 2,287 2025 2,421 2026 1,476 2027 578 2028 and thereafter 3,316 Total lease payments $ 10,556 Less: imputed interest (1,575) Less: tenant improvement allowance (1,015) Total $ 7,966 |
INVESTMENTS (Notes)
INVESTMENTS (Notes) | 9 Months Ended |
Sep. 30, 2023 | |
Investments [Abstract] | |
INVESTMENTS | INVESTMENTS Investments, Non-current, at Fair Value During the third quarter of 2021, the Company invested $3.0 million through a subordinated convertible promissory note (the "Note") of $3.0 million with a values-based career destination company that allows the next generation workforce to search for jobs at companies whose people, perks and values align with their unique professional needs. The Note earned interest at 6.00% and matured at the earlier of a Qualified Financing, as described in the Note, or settled in cash on or after August 20, 2022, at the option of the Company. Upon a Qualified Financing, the Company would convert its investment into shares of preferred stock at 80% of the per share value in the Qualified Financing. Prior to the Qualified Financing, the investment was recorded at $3.0 million and as a trading security at fair value with realized and unrealized gains and losses included in earnings. On September 20, 2022, a Qualified Financing occurred and the Note was converted into preferred shares representing 4.9% of the outstanding equity in the underlying business, on a fully-diluted basis. The Company's preferred shares are substantially similar to shares purchased by a third party investor in the Qualified Financing that resulted in such investor becoming the majority owner of the business, holding 50.5% of the outstanding equity in the business, on a fully-diluted basis. Therefore, the Company's shares in the business were recorded at fair value based on the price per share realized in the Qualified Financing. At September 30, 2022, the Company valued the investment at $0.7 million, and accordingly, recognized an impairment loss during the three month period ended September 30, 2022 of $2.3 million. During the nine month period ended September 30, 2023, the majority investor purchased additional shares of the business as was contemplated in, and at the same price as, in the Qualified Financing and additional equity based compensation was issued to the investment's management team. As a result, the majority investor's ownership was reduced to 44.8% and the Company's ownership was reduced to 4.1%, both on a fully-diluted basis, as of September 30, 2023. During the three month period ended September 30, 2023, the investment's financial position deteriorated. To meet its financial obligations, the investment issued convertible debt (the "Convertible Debt") at a price that indicated the value of the investment had declined. As such, the Company revalued its investment to $0.4 million and accordingly, recognized an impairment loss of $0.3 million during the three month period ended September 30, 2023. The Company has elected the measurement alternative in accordance with FASB ASC 321, Investments – Equity Securities. As of September 30, 2023, subsequent to the issuance of the Convertible Debt, it was not practicable to estimate the fair value of its interest because there were no observable transactions for the investment. Accordingly, the investment was carried at the value indicated by the Convertible Debt as of September 30, 2023, as described above. Investments, Non-current Rigzone is a website dedicated to delivering online content, data, and career services in the oil and gas industry in North America, Europe, the Middle East, and Asia Pacific. Oil and gas companies, as well as companies that serve the energy industry, use Rigzone to find talent for roles such as petroleum engineers, sales professionals with energy industry expertise and skilled tradesmen. On August 31, 2018, the Company transferred a majority ownership and control of the Rigzone business to Rigzone management, while retaining a 40% common share interest, with zero proceeds received from the transfer. During the second quarter of 2022, the Company sold its 40% interest in Rigzone to Rigzone management for $0.3 million. At the time of the sale, the recorded value of the investment was zero. Accordingly, the Company recognized a $0.3 million gain on sale, which was included in gain on investment on the condensed consolidated statements of operations. On June 30, 2021, the Company transferred majority ownership and control of its eFinancialCareers ("eFC") business to eFC's management, while retaining a 40% common share interest with zero proceeds received from the transfer. The Company incurred approximately $0.1 million in selling costs and recognized a $30.2 million loss on the transfer in the second quarter of 2021, which included a $28.1 million charge related to accumulated foreign currency loss that was previously a reduction to equity. During the three month period ended September 30, 2023, the Company sold a portion of its ownership in eFC reducing its total interest in eFC from 40% to 10%. As a result of the sale, the Company received cash of $4.9 million and recognized a $0.6 million gain, which included a $0.2 million charge related to accumulated foreign currency loss that was previously a reduction to equity. eFC is a financial services careers website, operating websites in multiple markets in four languages mainly across the United Kingdom, Continental Europe, Asia, the Middle East and North America. Professionals from across many sectors of the financial services industry, including asset management, risk management, investment banking, and information technology, use eFC to advance their careers. The Company has evaluated its common share interest in the eFC business and has determined the investment meets the definition and criteria of a variable interest entity ("VIE"). The Company evaluated the VIE and determined that the Company does not have a controlling financial interest in the VIE, as the Company does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance. The common share interest is being accounted for under the equity method of accounting as the Company has the ability to exercise significant influence over eFC. The investment was recorded at its fair value on June 30, 2021, the date of transfer, which was $3.6 million. The Company's equity in the net assets of eFC as of June 30, 2021 was $2.2 million. The difference between the Company's recorded value and its equity in net assets of eFC is amortized against the recorded value of the investment in accordance with ASC 323 Investments - Equity Method and Joint Ventures . Accordingly, the Company recorded amortization of $0.1 million for the three and nine month periods ended September 30, 2023. There was no amortization recorded during the three and nine month periods ended September 30, 2022 because it was not material. The recorded value is further adjusted based on the Company's proportionate share of eFC's net income and is recorded three months in arrears. The Company recorded income related to its proportionate share of eFC's net income, net of currency translation adjustments and amortization of the basis difference, of $0.2 million and $0.4 million for the three and nine month periods ended September 30, 2023, respectively, and recorded $0.6 million and $1.1 million for the three and nine month periods ended September 30, 2022, respectively. |
ACQUIRED INTANGIBLE ASSETS, NET
ACQUIRED INTANGIBLE ASSETS, NET | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets Disclosure | ACQUIRED INTANGIBLE ASSETS, NET Considering the recognition of the Dice brand, its long history, awareness in the talent acquisition and staffing services market, and the intended use, the remaining useful life of the Dice.com trademarks and brand name was determined to be indefinite. We determine whether the carrying value of recorded indefinite-lived acquired intangible assets is impaired on an annual basis or more frequently if indicators of potential impairment exist. The annual impairment test for the Dice.com trademarks and brand name is performed on October 1 of each year. The impairment review process compares the fair value of the indefinite-lived acquired intangible assets to its carrying value. If the carrying value exceeds the fair value, an impairment loss is recorded. As of September 30, 2023 and December 31, 2022, the Company had an indefinite-lived acquired intangible asset of $23.8 million related to the Dice trademarks and brand name. No impairment was recorded during the three and nine month periods ended September 30, 2023 and 2022. |
GOODWILL (Notes)
GOODWILL (Notes) | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill Disclosure [Text Block] | . GOODWILL Goodwill as of September 30, 2023 and December 31, 2022, which was allocated to the Tech-focused reporting unit, was $128.1 million. The annual impairment test for the Tech-focused reporting unit is performed on October 1 of each year. The results of the impairment test indicated that the fair value of the Tech-focused reporting unit was substantially in excess of the carrying value as of October 1, 2022. The projections utilized in the October 1, 2022 analysis included increasing revenue at rates approximating industry growth projections. The Company’s ability to achieve these revenue projections may be impacted by, among other things, general market conditions, competition in the technology recruiting market, challenges in developing and introducing new products and product enhancements to the market and the Company’s ability to attribute value delivered to customers. The October 1, 2022 analysis included operating margins during the year ending December 31, 2022 that approximate operating margins for the year |
INDEBTEDNESS
INDEBTEDNESS | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Debt Disclosure | INDEBTEDNESS Credit Agreement —In June 2022, the Company, together with Dice Inc. (a wholly-owned subsidiary of the Company) and its wholly-owned subsidiary, Dice Career Solutions, Inc. (collectively, the “Borrowers”), entered into a Third Amended and Restated Credit Agreement (the “Credit Agreement”), which matures in June 2027 and replaces the Company's Old Credit Agreement (defined below). The Credit Agreement provides for a revolving loan facility of $100 million ($90 million under the Old Credit Agreement), with an expansion option of $50 million, bringing the total facility to $150 million, as permitted under the terms of the Credit Agreement. At the closing of the Credit Agreement, the Company borrowed $30 million to repay, in full, all outstanding indebtedness, including accrued interest, under the Old Credit Agreement. Unamortized debt issuance costs from the previous credit agreement of $0.2 million and debt issuance costs of $0.5 million related to the new agreement were recorded as other assets on the condensed consolidated balance sheets and are recorded to interest expense over the term of the Credit Agreement. Borrowings under the Credit Agreement denominated in U.S. dollars bear interest, payable at least quarterly, at the Company’s option, at the Secured Overnight Financing Rate ("SOFR") or a base rate plus a margin. Borrowings under the Credit Agreement denominated in pounds sterling, if any, bear interest at the Sterling Overnight Index Average ("SONIA") rate plus a margin. The margin ranges from 2.00% to 2.75% on SOFR and SONIA loans and 1.00% to 1.75% on base rate loans, determined by the Company’s most recent consolidated leverage ratio, plus an additional spread of 0.10%. The Company incurs a commitment fee ranging from 0.35% to 0.50% on any unused capacity under the revolving loan facility, determined by the Company’s most recent consolidated leverage ratio. Borrowings in U.S. dollars as of September 30, 2023 and December 31, 2022 were $40 million and $30 million, respectively. There were no borrowings in pounds sterling as of September 30, 2023 and December 31, 2022. The facility may be prepaid at any time without penalty. The Credit Agreement contains various customary affirmative and negative covenants and also contains certain financial covenants, including a consolidated leverage ratio and a consolidated interest coverage ratio. Borrowings are allowed under the Credit Agreement to the extent the consolidated leverage ratio is equal to or less than 2.50 to 1.00, subject to the terms of the Credit Agreement. Negative covenants include restrictions on incurring certain liens; making certain payments, such as stock repurchases and dividend payments; making certain investments; making certain acquisitions; making certain dispositions; and incurring additional indebtedness. Restricted payments are allowed under the Credit Agreement to the extent the consolidated leverage ratio, calculated on a pro forma basis, is equal to or less than 2.00 to 1.00, plus an additional $7.5 million of restricted payments each fiscal year, as described in the Credit Agreement. The Credit Agreement also provides that the payment of obligations may be accelerated upon the occurrence of customary events of default, including, but not limited to, non-payment, change of control, or insolvency. As of September 30, 2023, the Company was in compliance with all of the financial covenants under the Credit Agreement. The obligations under the Credit Agreement are guaranteed by one of the Company’s wholly-owned subsidiaries and secured by substantially all of the assets of the Borrowers and the guarantors. Previous Credit Agreement - The Borrowers previously maintained a Second Amended and Restated Credit Agreement (the "Old Credit Agreement"), which was scheduled to mature in November 2023. The Old Credit Agreement, when entered into during November 2018, provided for a revolving loan facility of $90 million, with an expansion option of $50 million, bringing the total facility to $140 million, as permitted by the terms of the Old Credit Agreement. Borrowings under the Old Credit Agreement accrued interest, at the Company's option, at the London Inter-bank Offered Rate ("LIBOR") or a base rate plus a margin. The margin ranged from 1.75% to 2.50% on LIBOR loans and 0.75% to 1.50% on base rate loans, determined by the Company's most recent consolidated leverage ratio. The Company incurred a commitment fee ranging from 0.30% to 0.45% on any unused capacity under the revolving loan facility, determined by the Company’s most recent consolidated leverage ratio. The was no penalty for prepayment of the Old Credit Agreement. The amounts borrowed as of September 30, 2023 and December 31, 2022 are as follows (dollars in thousands): September 30, December 31, Long-term debt under revolving credit facility (1) $ 40,000 $ 30,000 Available to be borrowed under revolving facility (2) $ 60,000 $ 70,000 Interest rates: SOFR rate loans: Interest margin (3) 2.35 % 2.35 % Actual interest rates (4) 7.67 % 6.67 % Commitment fee 0.40 % 0.40 % (1) In connection with the Credit Agreement, during the three months ended September 30, 2023, the Company had deferred financing costs of $0.7 million recorded in other assets on the condensed consolidated balance sheets. Accumulated amortization as of September 30, 2023 was $0.2 million. (2) The amount available to be borrowed is subject to certain limitations, such as a consolidated leverage ratio, as defined in the Credit Agreement. (3) Includes additional spread of 0.10%. (4) Computed as the weighted average interest rate on all borrowings. There are no scheduled principal payments until maturity of the Credit Agreement in June 2027. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | . COMMITMENTS AND CONTINGENCIES Litigation The Company is subject to various claims from taxing authorities, lawsuits and other complaints arising in the ordinary course of business. The Company records provisions for losses when claims become probable and the amounts are reasonably estimable. Although the outcome of these legal matters, except as described below and recorded in the condensed consolidated financial statements, cannot be determined, it is the opinion of management that the final resolution of these matters will not have a material effect on the Company’s financial condition, operations or liquidity. Tax Contingencies The Company operates in a number of tax jurisdictions and is routinely subject to examinations by various tax authorities with respect to income taxes and indirect taxes. The determination of the Company’s liability for taxes requires judgment and estimation. The Company has reserved for potential examination adjustments to our provision for income taxes and accrual of indirect taxes in amounts which the Company believes are reasonable. |
EQUITY TRANSACTIONS (Notes)
EQUITY TRANSACTIONS (Notes) | 9 Months Ended |
Sep. 30, 2023 | |
Equity, Class of Treasury Stock [Line Items] | |
Stockholders' Equity Note Disclosure [Text Block] | EQUITY TRANSACTIONS Stock Repurchase Plans —The Company's Board of Directors ("Board") approved a stock repurchase program that permits the Company to repurchase its common stock. Management has discretion in determining the conditions under which shares may be purchased from time to time. The number, price, structure, and timing of the repurchases, if any, will be at our sole discretion and future repurchases will be evaluated by us depending on market conditions, liquidity needs, restrictions under the agreements governing our indebtedness, and other factors. Share repurchases may be made in the open market or in privately negotiated transactions. The repurchase authorization does not oblige us to acquire any particular amount of our common stock. The Board may suspend, modify, or terminate the repurchase program at any time without prior notice. The following table summarizes the stock repurchase plans approved by the Board: February 2021 to June 2022 (1) February 2022 to February 2023 (2) February 2023 to February 2024 (3) Approval Date February 2021 February 2022 February 2023 Authorized Repurchase Amount of Common Stock $20 million $15 million $10 million (1) During the second quarter of 2021, the Company amended its $8.0 million stock repurchase program approved in February 2021 and allowed for the purchase of an additional $12.0 million of our common stock through June 2022, bringing total authorized purchases under the plan to $20.0 million. During the first quarter of 2022, the Company completed its purchases under the plan, which consisted of approximately 4.4 million shares for $20.0 million, effectively ending the plan prior to its original expiration date. (2) During February 2023, the stock repurchase program approved in February 2022 expired with a total of 2.6 million shares purchased for $14.7 million. (3) On February 9, 2023, the Company announced that its Board approved a new stock repurchase program that permits the purchase of up to $10.0 million of the Company's common stock through February 2024. As of September 30, 2023 the value of shares that may yet be purchased under the current plan was $4.8 million. Purchases of the Company's common stock pursuant to the stock repurchase plans were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Shares repurchased — 719,777 1,661,278 2,647,072 Average purchase price per share (1) $ — $ 5.25 $ 4.17 $ 5.67 Dollar value of shares repurchased (in thousands) (1) $ — $ 3,777 $ 6,928 $ 15,016 (1) Average price paid per share and dollar value of shares repurchased include costs associated with the repurchases. There were 20,020 unsettled share repurchases as of September 30, 2022 and none as of September 30, 2023. Stock Repurchases Pursuant to the 2022 Omnibus Equity Award Plan, as Amended and Restated —Under the 2022 Omnibus Equity Award Plan, as Amended and Restated, and as further described in note 13 to the condensed consolidated financial statements, the Company repurchases its common stock withheld for income tax from the vesting of employee restricted stock or Performance-Based Restricted Stock Units (“PSUs”). The Company remits the value, which is based on the closing share price on the vesting date, of the common stock withheld to the appropriate tax authority on behalf of the employee and the related shares become treasury stock. Purchases of the Company’s common stock pursuant to the 2022 Omnibus Equity Award Plan, as Amended and Restated, were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Shares repurchased upon restricted stock/PSU vesting 218,432 76,180 1,143,583 913,609 Average purchase price per share $ 3.76 $ 4.98 $ 5.43 $ 5.42 Dollar value of shares repurchased upon restricted stock/PSU vesting (in thousands) $ 821 $ 379 $ 6,211 $ 4,951 No shares of the Company's common stock were purchased other than through the stock repurchase plans and the 2022 Omnibus Equity Award Plan, as Amended and Restated, as described above. |
STOCK BASED COMPENSATION
STOCK BASED COMPENSATION | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
STOCK BASED COMPENSATION | STOCK-BASED COMPENSATION On July 13, 2022, the stockholders of the Company approved the DHI Group, Inc. 2022 Omnibus Equity Award Plan, which had been previously approved by the Company's Board of Directors on May 13, 2022 (the "2022 Omnibus Equity Award Plan"). The 2022 Omnibus Equity Award Plan generally mirrors the terms of the Company's prior omnibus equity award plan, which expired in accordance with its terms on April 20, 2022 (the "2012 Omnibus Equity Award Plan"). On April 26, 2023, the stockholders of the Company approved the DHI Group, Inc. 2022 Omnibus Equity Award Plan, as Amended and Restated, which had been previously approved by the Company’s Board of Directors on March 16, 2023 (the "2022 Omnibus Equity Award Plan, as Amended and Restated"). The 2022 Omnibus Equity Award Plan was amended and restated to, among other things, increase the number of shares of common stock authorized for issuance as equity awards under the plan by 2.9 million shares. The Company has previously granted restricted stock and PSUs to certain employees and directors pursuant to the 2012 Omnibus Equity Award Plan and the 2022 Omnibus Equity Award Plan and will continue to grant restricted stock and PSUs to certain employees and directors pursuant to the 2022 Omnibus Equity Award Plan, as Amended and Restated. The Company also offers an Employee Stock Purchase Plan. The Company recorded total stock-based compensation expense of $2.2 million and $7.7 million during the three and nine month periods ended September 30, 2023, respectively, and $2.5 million and $7.2 million during the three and nine month periods ended September 30, 2022, respectively. At September 30, 2023, there was $11.6 million of unrecognized compensation expense related to unvested awards, which is expected to be recognized over a weighted-average period of approximately 1.4 years. Restricted Stock— Restricted stock is granted to employees of the Company and its subsidiaries, and to non-employee members of the Company’s Board. These shares are part of the compensation plan for services provided by the employees or Board members. The closing price of the Company’s stock on the date of grant is used to determine the fair value of the grants. The expense related to restricted stock grants is recorded over the vesting period as described below. There was no cash flow impact resulting from the grants. Restricted stock vests in various increments on the anniversaries of each grant, subject to the recipient’s continued employment or service through each applicable vesting date. Vesting occurs over one year for Board members and over two A summary of the status of restricted stock awards as of September 30, 2023 and 2022 and the changes during the periods then ended is presented below: Three Months Ended September 30, 2023 Three Months Ended September 30, 2022 Shares Weighted- Average Fair Value at Grant Date Shares Weighted- Average Fair Value at Grant Date Non-vested at beginning of the period 2,574,925 $ 4.82 2,686,073 $ 3.77 Granted 307,174 $ 3.57 288,831 $ 4.98 Forfeited (289,002) $ 5.45 (8,000) $ 5.17 Vested (360,325) $ 4.09 (239,502) $ 3.48 Non-vested at end of period 2,232,772 $ 4.69 2,727,402 $ 3.92 Expected to vest 2,232,772 $ 4.69 2,727,402 $ 3.92 Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Shares Weighted- Average Fair Value at Grant Date Shares Weighted- Average Fair Value at Grant Date Non-vested at beginning of the period 2,639,286 $ 3.96 3,371,832 $ 2.80 Granted 1,590,172 $ 5.17 1,221,331 $ 5.12 Forfeited (475,681) $ 5.24 (116,716) $ 3.32 Vested (1,521,005) $ 3.76 (1,749,045) $ 2.66 Non-vested at end of period 2,232,772 $ 4.69 2,727,402 $ 3.92 Expected to vest 2,232,772 $ 4.69 2,727,402 $ 3.92 —PSUs are granted to employees of the Company and its subsidiaries. These shares are granted under compensation agreements that are for services provided by the employees. The fair value of the PSUs is measured at the grant date fair value of the award, which was determined based on an analysis of the probable performance outcomes. The performance period is over one year and is based on the achievement of bookings targets during the year of grant, as defined in the applicable award agreement. The earned shares will then vest over a three year period, one-third on each of the first, second, and third anniversaries of the grant date, or if later, the date the Compensation Committee certifies the performance results with respect to the performance period. There was no cash flow impact resulting from the grants. A summary of the status of PSUs as of September 30, 2023 and 2022 and the changes during the periods then ended is presented below: Three Months Ended September 30, 2023 Three Months Ended September 30, 2022 Shares Weighted- Average Fair Value at Shares Weighted- Average Fair Value at Non-vested at beginning of the period 2,045,427 $ 4.78 2,110,496 $ 3.48 Granted 55,128 $ 3.56 — $ — Forfeited (429,685) $ 5.28 — $ — Vested (182,776) $ 3.77 — $ — Non-vested at end of period 1,488,094 $ 4.71 2,110,496 $ 3.48 Expected to vest 1,488,094 $ 4.71 2,110,496 $ 3.48 Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Shares Weighted- Average Fair Value at Shares Weighted- Average Fair Value at Non-vested at beginning of the period 2,086,932 $ 3.48 1,593,775 $ 2.62 Granted (1) 1,412,715 $ 5.54 1,553,332 $ 3.77 Forfeited (592,703) $ 5.14 (93,341) $ 2.40 Vested (1,418,850) $ 3.54 (943,270) $ 2.61 Non-vested at end of period 1,488,094 $ 4.71 2,110,496 $ 3.48 Expected to vest 1,488,094 $ 4.71 2,110,496 $ 3.48 (1) PSUs granted includes 587,587 additional PSUs granted during the first quarter of 2023 related to the bookings achievement for the performance period ended December 31, 2022. PSUs granted includes 853,332 additional PSUs granted during the first quarter of 2022 related to the bookings achievement for the performance period ended December 31, 2021. |
EARNINGS PER SHARE
EARNINGS PER SHARE | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | EARNINGS PER SHARE Basic earnings per share (“EPS”) is computed based on the weighted-average number of shares of common stock outstanding. Diluted EPS is computed based on the weighted-average number of shares of common stock outstanding plus common stock equivalents, where dilutive. The following is a calculation of basic and diluted earnings per share and weighted-average shares outstanding (in thousands, except per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net income (loss) $ 1,010 $ (926) $ 1,343 $ 1,825 Weighted-average shares outstanding—basic 43,405 44,190 43,582 44,503 Add shares issuable from stock-based awards (1) 919 — 997 2,208 Weighted-average shares outstanding—diluted 44,324 44,190 44,579 46,711 Basic earnings (loss) per share $ 0.02 $ (0.02) $ 0.03 $ 0.04 Diluted earnings (loss) per share $ 0.02 $ (0.02) $ 0.03 $ 0.04 Shares excluded from the calculation of diluted earnings per share (2) 1,961 — 2,217 1,058 (1) For the three months ended September 30, 2022, 2.1 million shares were excluded from the computation of shares contingently issuable upon exercise as we recognized a net loss. (2) Represents outstanding stock-based awards that were anti-dilutive and excluded from the calculation of diluted earnings per share. |
INCOME TAXES (Notes)
INCOME TAXES (Notes) | 9 Months Ended |
Sep. 30, 2023 | |
Income Tax Contingency [Line Items] | |
Income Tax Disclosure [Text Block] | INCOME TAXES The Company’s effective tax rate was 43% and (47)% for the three and nine months ended September 30, 2023, respectively, and 1% and (106)% for the three and nine months ended September 30, 2022, respectively. The following items caused the effective tax rate to differ from the U.S. statutory rate: • Tax benefits of $0.4 million during the nine months ended September 30, 2023, and $0.1 million and $1.1 million during the three and nine months ended September 30, 2022, respectively, from the vesting of share-based compensation awards. • Tax benefits of $0.4 million during the nine months ended September 30, 2023, and $0.1 million during the three months ended September 30, 2022, from research tax credits. • Tax expense of $0.1 million during the three months ended September 30, 2023, from deduction limitations on executive compensation. • Tax expense of $0.1 million and $0.5 million during the three months ended September 30, 2023 and 2022, respectively, from a valuation allowance related to the impairment of an investment. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Pay vs Performance Disclosure | ||||
Net income (loss) | $ 1,010 | $ (926) | $ 1,343 | $ 1,825 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Sep. 30, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue | The following table provides information about disaggregated revenue by brand and includes a reconciliation of the disaggregated revenue (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Dice (1) $ 24,770 $ 27,342 $ 77,952 $ 78,799 ClearanceJobs 12,663 11,185 36,639 31,119 Total $ 37,433 $ 38,527 $ 114,591 $ 109,918 (1) Includes Dice and Career Events |
Schedule of Contract Balances | The following table provides information about opening and closing balances of receivables and contract liabilities from contracts with customers as required under Topic 606 (in thousands): As of September 30, 2023 As of December 31, 2022 Receivables $ 18,591 $ 20,494 Short-term contract liabilities (deferred revenue) 48,331 50,121 Long-term contract liabilities (deferred revenue) 513 743 The Company recognized the following revenue as a result of changes in the contract liability balances in the respective periods (in thousands): Three Months Ended Nine Months Ended September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 Revenue recognized in the period from: Amounts included in the contract liability at the beginning of the period $ 26,958 $ 26,783 $ 44,660 $ 41,387 |
Schedule of Expected Timing of Satisfaction for Performance Obligations | The following table includes estimated deferred revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period (in thousands): Remainder of 2023 2024 2025 2026 Total Tech-focused $ 26,438 $ 22,136 $ 249 $ 21 $ 48,844 Credit Losses The Company is exposed to credit losses through the inability of its customers to make required payments on accounts receivable. The Company segments accounts receivable based on credit risk characteristics and estimates future losses for each segment based on historical trends and current market conditions, as applicable. Expected losses on accounts receivable are recorded as allowance for doubtful accounts in the condensed consolidated balance sheets and as an expense in the condensed consolidated statement of operations. The portion of accounts receivable that is reflected as deferred revenue in the condensed consolidated balance sheets is not considered at risk for credit losses. If the financial condition of DHI’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. |
LEASES (Tables)
LEASES (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Lease, Cost | The components of lease cost were as follows (in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease cost (1) $ 352 $ 592 $ 1,530 $ 1,636 Sublease income (25) (190) (324) (440) Total lease cost $ 327 $ 402 $ 1,206 $ 1,196 (1) Includes short-term lease costs and variable lease costs, which are immaterial. Supplemental cash flow information related to leases was as follows (in thousands): For the Nine Months Ended September 30, 2023 2022 Cash paid for amounts included in measurement of lease liabilities: Operating cash flows from operating leases $ 1,832 $ 675 |
Supplemental Balance Sheet Information | Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount): September 30, 2023 December 31, 2022 Operating lease right-of-use-assets $ 5,096 $ 6,581 Operating lease liabilities - current 1,984 2,231 Less: tenant improvement allowance (1,015) (2,126) Operating lease liabilities - current (as reported) 969 105 Operating lease liabilities - non-current (as reported) 6,997 8,428 Total operating lease liabilities $ 7,966 $ 8,533 Weighted Average Remaining Lease Term (in years) Operating leases 6.1 5.8 Weighted Average Discount Rate Operating leases 4.5 % 4.4 % |
Schedule of Maturities of Lease Liabilities | were as follows (in thousands): Operating Leases October 1, 2023 through December 31, 2023 $ 478 2024 2,287 2025 2,421 2026 1,476 2027 578 2028 and thereafter 3,316 Total lease payments $ 10,556 Less: imputed interest (1,575) Less: tenant improvement allowance (1,015) Total $ 7,966 |
INDEBTEDNESS (Tables)
INDEBTEDNESS (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Debt | The amounts borrowed as of September 30, 2023 and December 31, 2022 are as follows (dollars in thousands): September 30, December 31, Long-term debt under revolving credit facility (1) $ 40,000 $ 30,000 Available to be borrowed under revolving facility (2) $ 60,000 $ 70,000 Interest rates: SOFR rate loans: Interest margin (3) 2.35 % 2.35 % Actual interest rates (4) 7.67 % 6.67 % Commitment fee 0.40 % 0.40 % (1) In connection with the Credit Agreement, during the three months ended September 30, 2023, the Company had deferred financing costs of $0.7 million recorded in other assets on the condensed consolidated balance sheets. Accumulated amortization as of September 30, 2023 was $0.2 million. (2) The amount available to be borrowed is subject to certain limitations, such as a consolidated leverage ratio, as defined in the Credit Agreement. (3) Includes additional spread of 0.10%. (4) Computed as the weighted average interest rate on all borrowings. |
EQUITY TRANSACTIONS (Tables)
EQUITY TRANSACTIONS (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Class of Treasury Stock [Table Text Block] | Stock Repurchase Plans —The Company's Board of Directors ("Board") approved a stock repurchase program that permits the Company to repurchase its common stock. Management has discretion in determining the conditions under which shares may be purchased from time to time. The number, price, structure, and timing of the repurchases, if any, will be at our sole discretion and future repurchases will be evaluated by us depending on market conditions, liquidity needs, restrictions under the agreements governing our indebtedness, and other factors. Share repurchases may be made in the open market or in privately negotiated transactions. The repurchase authorization does not oblige us to acquire any particular amount of our common stock. The Board may suspend, modify, or terminate the repurchase program at any time without prior notice. The following table summarizes the stock repurchase plans approved by the Board: February 2021 to June 2022 (1) February 2022 to February 2023 (2) February 2023 to February 2024 (3) Approval Date February 2021 February 2022 February 2023 Authorized Repurchase Amount of Common Stock $20 million $15 million $10 million (1) During the second quarter of 2021, the Company amended its $8.0 million stock repurchase program approved in February 2021 and allowed for the purchase of an additional $12.0 million of our common stock through June 2022, bringing total authorized purchases under the plan to $20.0 million. During the first quarter of 2022, the Company completed its purchases under the plan, which consisted of approximately 4.4 million shares for $20.0 million, effectively ending the plan prior to its original expiration date. (2) During February 2023, the stock repurchase program approved in February 2022 expired with a total of 2.6 million shares purchased for $14.7 million. (3) On February 9, 2023, the Company announced that its Board approved a new stock repurchase program that permits the purchase of up to $10.0 million of the Company's common stock through February 2024. |
Schedule of Repurchase Agreements [Table Text Block] | Purchases of the Company's common stock pursuant to the stock repurchase plans were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Shares repurchased — 719,777 1,661,278 2,647,072 Average purchase price per share (1) $ — $ 5.25 $ 4.17 $ 5.67 Dollar value of shares repurchased (in thousands) (1) $ — $ 3,777 $ 6,928 $ 15,016 (1) Average price paid per share and dollar value of shares repurchased include costs associated with the repurchases. |
Cash Proceeds Received and Tax Benefit from Share-based Payment Awards | Purchases of the Company’s common stock pursuant to the 2022 Omnibus Equity Award Plan, as Amended and Restated, were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Shares repurchased upon restricted stock/PSU vesting 218,432 76,180 1,143,583 913,609 Average purchase price per share $ 3.76 $ 4.98 $ 5.43 $ 5.42 Dollar value of shares repurchased upon restricted stock/PSU vesting (in thousands) $ 821 $ 379 $ 6,211 $ 4,951 No shares of the Company's common stock were purchased other than through the stock repurchase plans and the 2022 Omnibus Equity Award Plan, as Amended and Restated, as described above. |
STOCK BASED COMPENSATION (Table
STOCK BASED COMPENSATION (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Nonvested Share Activity | A summary of the status of restricted stock awards as of September 30, 2023 and 2022 and the changes during the periods then ended is presented below: Three Months Ended September 30, 2023 Three Months Ended September 30, 2022 Shares Weighted- Average Fair Value at Grant Date Shares Weighted- Average Fair Value at Grant Date Non-vested at beginning of the period 2,574,925 $ 4.82 2,686,073 $ 3.77 Granted 307,174 $ 3.57 288,831 $ 4.98 Forfeited (289,002) $ 5.45 (8,000) $ 5.17 Vested (360,325) $ 4.09 (239,502) $ 3.48 Non-vested at end of period 2,232,772 $ 4.69 2,727,402 $ 3.92 Expected to vest 2,232,772 $ 4.69 2,727,402 $ 3.92 Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Shares Weighted- Average Fair Value at Grant Date Shares Weighted- Average Fair Value at Grant Date Non-vested at beginning of the period 2,639,286 $ 3.96 3,371,832 $ 2.80 Granted 1,590,172 $ 5.17 1,221,331 $ 5.12 Forfeited (475,681) $ 5.24 (116,716) $ 3.32 Vested (1,521,005) $ 3.76 (1,749,045) $ 2.66 Non-vested at end of period 2,232,772 $ 4.69 2,727,402 $ 3.92 Expected to vest 2,232,772 $ 4.69 2,727,402 $ 3.92 A summary of the status of PSUs as of September 30, 2023 and 2022 and the changes during the periods then ended is presented below: Three Months Ended September 30, 2023 Three Months Ended September 30, 2022 Shares Weighted- Average Fair Value at Shares Weighted- Average Fair Value at Non-vested at beginning of the period 2,045,427 $ 4.78 2,110,496 $ 3.48 Granted 55,128 $ 3.56 — $ — Forfeited (429,685) $ 5.28 — $ — Vested (182,776) $ 3.77 — $ — Non-vested at end of period 1,488,094 $ 4.71 2,110,496 $ 3.48 Expected to vest 1,488,094 $ 4.71 2,110,496 $ 3.48 Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Shares Weighted- Average Fair Value at Shares Weighted- Average Fair Value at Non-vested at beginning of the period 2,086,932 $ 3.48 1,593,775 $ 2.62 Granted (1) 1,412,715 $ 5.54 1,553,332 $ 3.77 Forfeited (592,703) $ 5.14 (93,341) $ 2.40 Vested (1,418,850) $ 3.54 (943,270) $ 2.61 Non-vested at end of period 1,488,094 $ 4.71 2,110,496 $ 3.48 Expected to vest 1,488,094 $ 4.71 2,110,496 $ 3.48 (1) PSUs granted includes 587,587 additional PSUs granted during the first quarter of 2023 related to the bookings achievement for the performance period ended December 31, 2022. PSUs granted includes 853,332 additional PSUs granted during the first quarter of 2022 related to the bookings achievement for the performance period ended December 31, 2021. |
Weighted Average Remaining Contractual Life | Employee Stock Purchase Plan—On March 11, 2020 the Company's Board of Directors adopted an Employee Stock Purchase Plan ("ESPP"). The ESPP was approved by the Company's stockholders on April 21, 2020. The ESPP provides eligible employees the opportunity to purchase shares of the Company's common stock through payroll deductions during six-month offering periods. The purchase price per share of common stock is 85% of the lower of the closing stock price on the first or last trading day of each offering period. The offering periods are January 1 to June 30 and July 1 to December 31. The maximum number of shares of common stock available for purchase under the ESPP is 500,000, subject to adjustment as provided under the ESPP. Individual employee purchases are limited to $25,000 per calendar year, based on the fair market value of the shares on the purchase date. No shares were issued during the three months ended September 30, 2023 and 2022. During the nine months ended September 30, 2023 and 2022, 45,374 and 29,253 shares, respectively, were issued under the plan. |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following is a calculation of basic and diluted earnings per share and weighted-average shares outstanding (in thousands, except per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net income (loss) $ 1,010 $ (926) $ 1,343 $ 1,825 Weighted-average shares outstanding—basic 43,405 44,190 43,582 44,503 Add shares issuable from stock-based awards (1) 919 — 997 2,208 Weighted-average shares outstanding—diluted 44,324 44,190 44,579 46,711 Basic earnings (loss) per share $ 0.02 $ (0.02) $ 0.03 $ 0.04 Diluted earnings (loss) per share $ 0.02 $ (0.02) $ 0.03 $ 0.04 Shares excluded from the calculation of diluted earnings per share (2) 1,961 — 2,217 1,058 (1) For the three months ended September 30, 2022, 2.1 million shares were excluded from the computation of shares contingently issuable upon exercise as we recognized a net loss. (2) Represents outstanding stock-based awards that were anti-dilutive and excluded from the calculation of diluted earnings per share. |
SIGNIFCANT ACCOUNTING POLICIE_2
SIGNIFCANT ACCOUNTING POLICIES (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Jun. 30, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | |
Accounting Policies [Abstract] | |||
Financing Receivable, Allowance for Credit Losses, Effect of Change in Method | $ 300 | ||
Interest in Diluted Shares of Cost Method Investment | 4.10% | 4.90% |
Revenue Recognition - Disaggreg
Revenue Recognition - Disaggregated Revenue (Details) - Tech-Focused [Member] - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Disaggregation of Revenue [Line Items] | ||||
Disaggregated revenue | $ 37,433 | $ 38,527 | $ 114,591 | $ 109,918 |
Dice [Member] | ||||
Disaggregation of Revenue [Line Items] | ||||
Disaggregated revenue | 24,770 | 27,342 | 77,952 | 78,799 |
ClearanceJobs [Member] | ||||
Disaggregation of Revenue [Line Items] | ||||
Disaggregated revenue | $ 12,663 | $ 11,185 | $ 36,639 | $ 31,119 |
REVENUE RECOGNITION Revenue Rec
REVENUE RECOGNITION Revenue Recognition - Contract Balances (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |||||
Accounts receivable, net of allowance for doubtful accounts of $758 and $647 | $ 18,591 | $ 18,591 | $ 20,494 | ||
Deferred revenue | 48,331 | 48,331 | 50,121 | ||
Deferred Revenue, Noncurrent | 513 | 513 | $ 743 | ||
Amounts included in the contract liability at the beginning of the period | $ 26,958 | $ 26,783 | $ 44,660 | $ 41,387 |
REVENUE RECOGNITION Revenue R_2
REVENUE RECOGNITION Revenue Recognition - Performance Obligations (Details) - Tech [Member] $ in Thousands | Sep. 30, 2023 USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Tech-focused revenue, remaining performance obligation | $ 48,844 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Tech-focused revenue, remaining performance obligation | $ 26,438 |
Tech-focused revenue, expected timing of satisfaction | 3 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Tech-focused revenue, remaining performance obligation | $ 22,136 |
Tech-focused revenue, expected timing of satisfaction | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Tech-focused revenue, remaining performance obligation | $ 249 |
Tech-focused revenue, expected timing of satisfaction | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Tech-focused revenue, remaining performance obligation | $ 21 |
Tech-focused revenue, expected timing of satisfaction | 1 year |
RESTRUCTURE COSTS (Details)
RESTRUCTURE COSTS (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||
May 31, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring and related cost, number of positions eliminated, period percent | 10% | ||||
Restructuring costs | $ 302 | $ 0 | $ 2,417 | $ 0 | |
Severance Costs | $ 100 | $ 1,900 | |||
Employee Severance | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Payments for restructuring | 900 | 1,400 | |||
Accelerated Stock-Based Compensation | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Payments for restructuring | $ 200 | $ 500 |
LEASES (Details)
LEASES (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Lessee, Lease, Description [Line Items] | |||||
Operating lease right-of-use-assets | $ 5,096,000 | $ 5,096,000 | $ 6,581,000 | ||
Operating lease liability | 7,966,000 | 7,966,000 | $ 8,533,000 | ||
Operating lease, impairment loss | $ 0 | $ 0 | $ 0 | $ 0 | |
Minimum | |||||
Lessee, Lease, Description [Line Items] | |||||
Lease term of contract (in years) | 1 year | 1 year | |||
Maximum | |||||
Lessee, Lease, Description [Line Items] | |||||
Lease term of contract (in years) | 11 years | 11 years |
LEASES (Lease Cost) (Details)
LEASES (Lease Cost) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Leases [Abstract] | ||||
Operating lease cost(1) | $ 352 | $ 592 | $ 1,530 | $ 1,636 |
Sublease income | (25) | (190) | (324) | (440) |
Total lease cost | $ 327 | $ 402 | 1,206 | 1,196 |
Cash paid for amounts included in measurement of lease liabilities: | ||||
Operating cash flows from operating leases | $ 1,832 | $ 675 |
LEASES (Supplemental Balance Sh
LEASES (Supplemental Balance Sheet Information) (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Leases [Abstract] | ||
Operating lease right-of-use-assets | $ 5,096 | $ 6,581 |
Operating Lease, Liability, Current, Before Allowance for Tenant Improvement | 1,984 | 2,231 |
Operating lease liabilities - current | 969 | 105 |
Operating lease liabilities - non-current (as reported) | 6,997 | 8,428 |
Total operating lease liabilities | $ 7,966 | $ 8,533 |
Weighted Average Remaining Lease Term (in years) | ||
Operating leases | 6 years 1 month 6 days | 5 years 9 months 18 days |
Weighted Average Discount Rate | ||
Operating leases | 4.50% | 4.40% |
Lessee, Operating Lease, Liability, Tenant Improvement Allowance | $ (1,015) | $ (2,126) |
LEASES (Maturities of Lease Lia
LEASES (Maturities of Lease Liabilities) (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Operating Lease, After Adoption of 842 | ||
October 1, 2023 through December 31, 2023 | $ 478 | |
2024 | 2,287 | |
2025 | 2,421 | |
2026 | 1,476 | |
2027 | 578 | |
2028 and thereafter | 3,316 | |
Lessee, Operating Lease, Liability, Payments, Due | 10,556 | |
Less: imputed interest | (1,575) | |
Total | 7,966 | $ 8,533 |
Lessee, Operating Lease, Liability, Tenant Improvement Allowance | $ (1,015) | $ (2,126) |
INVESTMENTS (Details)
INVESTMENTS (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||||||
Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Jun. 30, 2021 | Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2023 | Sep. 30, 2021 | Aug. 31, 2018 | |
Segment Reporting Information [Line Items] | |||||||||
Equity Method Investment, Underlying Equity in Net Assets | $ 2,200,000 | ||||||||
Proceeds from Sale of Equity Method Investments | $ 4,941,000 | $ 320,000 | |||||||
Interest in Diluted Shares of Cost Method Investment | 4.10% | 4.90% | 4.10% | 4.90% | |||||
Investments, Fair Value Disclosure | 3,000,000 | $ 3,000,000 | |||||||
Convertible Notes Payable | $ 3,000,000 | ||||||||
Investment Interest Rate | 7.30% | 7.30% | 6% | ||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Percent Equity Securities | 44.80% | 44.80% | 50.50% | 80% | |||||
Equity securities, FV-NI, gain (loss) | $ 614,000 | $ 320,000 | |||||||
Equity Method Investments, Fair Value Disclosure | $ 3,600,000 | ||||||||
Impairment on investment | $ 300,000 | $ 2,300,000 | 300,000 | 2,300,000 | |||||
Debt and Equity Securities, Unrealized Gain (Loss) | 614,000 | 0 | 614,000 | 320,000 | |||||
Investment Owned, at Fair Value | 400,000 | 400,000 | $ 700,000 | ||||||
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | (153,000) | (591,000) | (428,000) | (1,107,000) | |||||
Debt and Equity Securities, Unrealized Gain (Loss) | 614,000 | 0 | 614,000 | 320,000 | |||||
eFinancial Careers | |||||||||
Segment Reporting Information [Line Items] | |||||||||
Amortization | 100,000 | 0 | |||||||
Rigzone | |||||||||
Segment Reporting Information [Line Items] | |||||||||
Gain (Loss) on Sale of Investments | $ 300,000 | ||||||||
Proceeds from Sale of Equity Method Investments | $ 300,000 | ||||||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners, Common Stock Interest | 40% | 40% | |||||||
eFinancial Careers | |||||||||
Segment Reporting Information [Line Items] | |||||||||
Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease) | $ 200,000 | $ 600,000 | 400,000 | $ 1,100,000 | |||||
Proceeds from Sale of Equity Method Investments | $ 4,900,000 | ||||||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners, Common Stock Interest | 10% | 40% | 10% | 40% | |||||
Divestiture of business selling costs | $ 100,000 | ||||||||
Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses) | 28,100,000 | $ 200,000 | |||||||
Equity securities, FV-NI, gain (loss) | $ 30,200,000 | ||||||||
Debt and Equity Securities, Unrealized Gain (Loss) | 600,000 | ||||||||
Debt and Equity Securities, Unrealized Gain (Loss) | $ 600,000 |
ACQUIRED INTANGIBLE ASSETS, N_2
ACQUIRED INTANGIBLE ASSETS, NET (Summary of Acquired Intangible Assets) (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Finite-Lived Intangible Assets [Line Items] | |||||
Acquired intangible assets, net | $ 23,800,000 | $ 23,800,000 | $ 23,800,000 | ||
Impairment of intangible assets, indefinite-lived | $ 0 | $ 0 | $ 0 | $ 0 |
GOODWILL (Details)
GOODWILL (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Goodwill [Line Items] | ||
Goodwill | $ 128,100 | $ 128,100 |
INDEBTEDNESS (Details)
INDEBTEDNESS (Details) $ in Thousands | 3 Months Ended | 6 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Mar. 31, 2019 USD ($) | Jun. 30, 2023 | Sep. 30, 2023 USD ($) Rate | Sep. 30, 2023 GBP (£) | Dec. 31, 2022 USD ($) | Dec. 31, 2022 GBP (£) | Nov. 30, 2018 USD ($) | |
Debt Instrument [Line Items] | |||||||||
Interest margin | 2.35% | 2.35% | |||||||
restricted payments under the Credit Agreement | $ 7,500 | ||||||||
Maximum available to be borrowed under revolving facility | $ 150,000 | $ 140,000 | |||||||
Total borrowed | $ 40,000 | $ 40,000 | £ 0 | $ 30,000 | £ 0 | ||||
Line of Credit Facility, Current Borrowing Capacity | 100,000 | 90,000 | |||||||
Debt instrument, additional spread | Rate | 0.10% | ||||||||
Line of Credit Facility, Commitment Fee Percentage | 0.40% | 0.40% | |||||||
Unamortized Debt Issuance Expense | 500 | $ 200 | |||||||
Securities Borrowed | 30,000 | ||||||||
Line of Credit Facility, Increase (Decrease), Net | $ 50,000 | $ 50,000 | |||||||
Minimum | |||||||||
Debt Instrument [Line Items] | |||||||||
Interest margin | 1.75% | 2% | |||||||
Ratio of Indebtedness to Net Capital, Pro forma basis | 1 | 1 | 1 | ||||||
Line of Credit Facility, Commitment Fee Percentage | 0.35% | 0.30% | |||||||
Minimum | Base Rate [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Interest margin | 0.75% | 1% | |||||||
Maximum | |||||||||
Debt Instrument [Line Items] | |||||||||
Interest margin | 2.50% | 2.75% | |||||||
Ratio of Indebtedness to Net Capital, Pro forma basis | 2 | 2 | 2 | ||||||
Line of Credit Facility, Commitment Fee Percentage | 0.50% | 0.45% | |||||||
Maximum | Base Rate [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Interest margin | 1.50% | 1.75% | |||||||
Borrowings [Member] | Minimum | |||||||||
Debt Instrument [Line Items] | |||||||||
Ratio of Indebtedness to Net Capital, Pro forma basis | 1 | 1 | 1 | ||||||
Borrowings [Member] | Maximum | |||||||||
Debt Instrument [Line Items] | |||||||||
Ratio of Indebtedness to Net Capital, Pro forma basis | 2.50 | 2.50 | 2.50 |
INDEBTEDNESS (Schedule of Credi
INDEBTEDNESS (Schedule of Credit Agreement) (Details) $ in Thousands | 6 Months Ended | 9 Months Ended | ||||
Jun. 30, 2023 | Sep. 30, 2023 USD ($) Rate | Sep. 30, 2023 GBP (£) | Dec. 31, 2022 USD ($) | Dec. 31, 2022 GBP (£) | Sep. 30, 2022 USD ($) | |
Debt Instrument [Line Items] | ||||||
Revolving credit facility | $ 40,000 | |||||
Accumulated amortization of deferred financing costs | 200 | |||||
Total borrowed | 40,000 | £ 0 | $ 30,000 | £ 0 | ||
Line of Credit Facility, Remaining Borrowing Capacity | $ 60,000 | $ 70,000 | ||||
Interest margin | 2.35% | 2.35% | ||||
Actual interest rates | 7.67% | 7.67% | 6.67% | 6.67% | ||
Line of Credit Facility, Commitment Fee Percentage | 0.40% | 0.40% | ||||
Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Gross | $ 700 | |||||
Debt instrument, additional spread | Rate | 0.10% |
EQUITY TRANSACTIONS (Details)
EQUITY TRANSACTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||||
Sep. 30, 2023 | Jun. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Feb. 09, 2023 | Feb. 01, 2022 | Sep. 30, 2021 | Feb. 01, 2021 | May 01, 2020 | |
Equity, Class of Treasury Stock [Line Items] | ||||||||||
Stock Repurchased During Period, Shares | 0 | 719,777,000 | 1,661,278,000 | 2,647,072,000 | ||||||
Stock Repurchase Program, Not Settled | 0 | 20,020 | 0 | 20,020 | ||||||
Average purchase price per share (in dollars per share) | $ 0 | $ 5.25 | $ 4.17 | $ 5.67 | ||||||
Payments for Repurchase of Common Stock, Gross | $ 0 | $ 3,777 | $ 6,928 | $ 15,016 | ||||||
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $ 4,800 | $ 4,800 | ||||||||
Stock Repurchase Program, Authorized Amount | $ 10,000 | $ 15,000 | $ 20,000 | |||||||
2021 | ||||||||||
Equity, Class of Treasury Stock [Line Items] | ||||||||||
Stock Repurchase Program, Authorized Amount | $ 8,000 | |||||||||
Stock Repurchased and Retired During Period, Shares | 4,400,000 | |||||||||
Treasury Stock, Value | $ 20,000 | |||||||||
Stock Repurchase Program, Additional Authorized Amount | 12,000 | |||||||||
Stock Repurchase Program, Authorized Adjustment | $ 20,000 | |||||||||
2022 | ||||||||||
Equity, Class of Treasury Stock [Line Items] | ||||||||||
Stock Repurchased During Period, Shares | 2,600,000 | |||||||||
Treasury Stock, Value | $ 14,700 | |||||||||
2023 | ||||||||||
Equity, Class of Treasury Stock [Line Items] | ||||||||||
Stock Repurchase Program, Authorized Amount | $ 10,000 |
EQUITY TRANSACTIONS - Cash Proc
EQUITY TRANSACTIONS - Cash Proceeds Received and Tax Benefit from Share-based Payment Awards (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Average purchase price per share (in dollars per share) | $ 0 | $ 5.25 | $ 4.17 | $ 5.67 |
Restricted Stock And Performance-Based Restricted Stock Units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares repurchased upon RSU/PSU vesting (in shares) | 218,432 | 76,180 | 1,143,583 | 913,609 |
Average purchase price per share (in dollars per share) | $ 3.76 | $ 4.98 | $ 5.43 | $ 5.42 |
Dollar value of shares repurchased upon restricted stock/PSU vesting (in thousands) | $ 821 | $ 379 | $ 6,211 | $ 4,951 |
STOCK BASED COMPENSATION (Detai
STOCK BASED COMPENSATION (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Stock based compensation expense | $ 2,200 | $ 2,500 | $ 7,700 | $ 7,200 | ||||
Unrecognized compensation expense | $ 11,600 | $ 11,600 | ||||||
Nonvested award, cost not yet recognized, period for recognition | 1 year 4 months 24 days | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 1 year 4 months 24 days | |||||||
Stock Issued During Period, Value, Employee Stock Purchase Plan | $ 0 | $ 0 | ||||||
Common stock, shares authorized | 240,000,000 | 240,000,000 | 240,000,000 | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | 85% | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee | 500,000 | |||||||
Stock Issued During Period, Value, Employee Stock Purchase Plan | $ 0 | $ 0 | ||||||
Common stock, shares authorized | 240,000,000 | 240,000,000 | 240,000,000 | |||||
Stock Issued During Period, Shares, Employee Stock Ownership Plan | 45,374 | 29,253 | ||||||
Restricted Stock | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Non-vested (in shares) | 2,232,772 | 2,574,925 | 2,727,402 | 2,686,073 | 2,232,772 | 2,727,402 | 2,639,286 | 3,371,832 |
Restricted Stock | Board Member | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Award vesting period | 1 year | |||||||
Performance Stock Units | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Award vesting period | 3 years | |||||||
Performance period | 1 year | |||||||
Non-vested (in shares) | 1,488,094 | 2,045,427 | 2,110,496 | 2,110,496 | 1,488,094 | 2,110,496 | 2,086,932 | 1,593,775 |
Performance Stock Units | Share-Based Payment Arrangement, Tranche One | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Award vesting rights, percentage | 33% | |||||||
Performance Stock Units | Share-Based Payment Arrangement, Tranche Two | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Award vesting rights, percentage | 33% | |||||||
Performance Stock Units | Share-Based Payment Arrangement, Tranche Three | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Award vesting rights, percentage | 33% | |||||||
2022 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Common stock, shares authorized | 2,900,000 | 2,900,000 | ||||||
Common stock, shares authorized | 2,900,000 | 2,900,000 | ||||||
Minimum | Restricted Stock | Employee | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Award vesting period | 2 years | |||||||
Maximum | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Stock Issued During Period, Value, Employee Stock Purchase Plan | $ 25 | |||||||
Stock Issued During Period, Value, Employee Stock Purchase Plan | $ 25 | |||||||
Maximum | Restricted Stock | Employee | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Award vesting period | 4 years |
STOCK BASED COMPENSATION (Statu
STOCK BASED COMPENSATION (Status of Restricted Stock) (Details) - $ / shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Restricted Stock | ||||
Shares | ||||
Non-vested at beginning of period (in shares) | 2,574,925 | 2,686,073 | 2,639,286 | 3,371,832 |
Granted (in shares) | 307,174 | 288,831 | 1,590,172 | 1,221,331 |
Forfeited (in shares) | 289,002 | 8,000 | 475,681 | 116,716 |
Vested (in shares) | 360,325 | 239,502 | 1,521,005 | 1,749,045 |
Non-vested at end of period (in shares) | 2,232,772 | 2,727,402 | 2,232,772 | 2,727,402 |
Weighted- Average Fair Value at Grant Date | ||||
Non-vested at beginning of the period (in usd per share) | $ 4.82 | $ 3.77 | $ 3.96 | $ 2.80 |
Granted (in usd per share) | 3.57 | 4.98 | 5.17 | 5.12 |
Forfeited (in usd per share) | 5.45 | 5.17 | 5.24 | 3.32 |
Vested (in usd per share) | 4.09 | 3.48 | 3.76 | 2.66 |
Non-vested at end of period (in usd per share) | $ 4.69 | $ 3.92 | $ 4.69 | $ 3.92 |
Performance Stock Units | ||||
Shares | ||||
Non-vested at beginning of period (in shares) | 2,045,427 | 2,110,496 | 2,086,932 | 1,593,775 |
Granted (in shares) | 55,128 | 0 | 1,412,715 | 1,553,332 |
Forfeited (in shares) | 429,685 | 0 | 592,703 | 93,341 |
Vested (in shares) | 182,776 | 0 | 1,418,850 | 943,270 |
Non-vested at end of period (in shares) | 1,488,094 | 2,110,496 | 1,488,094 | 2,110,496 |
Weighted- Average Fair Value at Grant Date | ||||
Non-vested at beginning of the period (in usd per share) | $ 4.78 | $ 3.48 | $ 3.48 | $ 2.62 |
Granted (in usd per share) | 3.56 | 0 | 5.54 | 3.77 |
Forfeited (in usd per share) | 5.28 | 0 | 5.14 | 2.40 |
Vested (in usd per share) | 3.77 | 0 | 3.54 | 2.61 |
Non-vested at end of period (in usd per share) | $ 4.71 | $ 3.48 | $ 4.71 | $ 3.48 |
Performance Stock Units | 2021 | ||||
Shares | ||||
Granted (in shares) | 853,332 | |||
Performance Stock Units | 2022 | ||||
Shares | ||||
Granted (in shares) | 587,587 |
STOCK BASED COMPENSATION Status
STOCK BASED COMPENSATION Status of PSUs (Details) - Performance Stock Units - $ / shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Shares | ||||
Non-vested at beginning of period (in shares) | 2,045,427 | 2,110,496 | 2,086,932 | 1,593,775 |
Granted (in shares) | 55,128 | 0 | 1,412,715 | 1,553,332 |
Forfeited (in shares) | (429,685) | 0 | (592,703) | (93,341) |
Vested (in shares) | (182,776) | 0 | (1,418,850) | (943,270) |
Non-vested at end of period (in shares) | 1,488,094 | 2,110,496 | 1,488,094 | 2,110,496 |
Weighted- Average Fair Value at Grant Date | ||||
Non-vested at beginning of the period (in usd per share) | $ 4.78 | $ 3.48 | $ 3.48 | $ 2.62 |
Forfeited (in usd per share) | 5.28 | 0 | 5.14 | 2.40 |
Granted (in usd per share) | 3.56 | 0 | 5.54 | 3.77 |
Vested (in usd per share) | 3.77 | 0 | 3.54 | 2.61 |
Non-vested at end of period (in usd per share) | $ 4.71 | $ 3.48 | $ 4.71 | $ 3.48 |
2021 | ||||
Shares | ||||
Granted (in shares) | 853,332 |
EARNINGS PER SHARE (Details)
EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Earnings Per Share [Abstract] | ||||
Income from continuing operations- basic and diluted | $ 1,010 | $ (926) | $ 1,343 | $ 1,825 |
Weighted average shares outstanding-basic | 43,405 | 44,190 | 43,582 | 44,503 |
Weighted Average Number Diluted Shares Outstanding Adjustment | 919 | 0 | 997 | 2,208 |
Options to purchase shares | 1,961 | 0 | 2,217 | 1,058 |
Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares | 2,100 | |||
Weighted average diluted shares outstanding | 44,324 | 44,190 | 44,579 | 46,711 |
Basic earnings (loss) per share (in dollars per share) | $ 0.02 | $ (0.02) | $ 0.03 | $ 0.04 |
Diluted earnings (loss) per share (in dollars per share) | $ 0.02 | $ (0.02) | $ 0.03 | $ 0.04 |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
INCOME TAXES [Abstract] | ||||
Effective Income Tax Rate Reconciliation, Percent | 43% | 1% | (47.00%) | (106.00%) |
Share-based Payment Arrangement, Expense, Tax Benefit | $ 100 | $ 400 | $ 1,100 | |
Deferred income taxes | (3,179) | (3,682) | ||
Deferred Tax Assets, Tax Credit Carryforwards | $ 400 | 100 | $ 400 | $ 100 |
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 100 | $ 500 | ||
Executive Compensation | $ 100 |